Biofidelity appoints Stephen Miller as Chief Commercial OfficerExperienced US-based commercial leader joins Biofidelity prior to launch of disruptive cancer diagnostic platform

Biofidelity Ltd, the cancer diagnostics company, announces the appointment of Stephen Miller as Chief Commercial Officer, based in the US. Following Biofidelity’s recent $12m Series A financing, supported by experienced investors BlueYard Capital, Longwall Ventures and Agilent Technologies, the Company is now focused on expanding its executive team, a critical step in its commercial strat